Abstract
Currently, Candida auris (C. auris) (infections in healthcare settings have become increasingly concerning due to their antifungal resistance and the difficulties associated with preventing cross-contamination. Since 2021, C. auris cases and outbreaks have been reported in several provinces across our country. This rapidly spreading Candida species represents a healthcare-associated infection that is particularly challenging to control due to its resistance profile. It easily colonizes and causes infections in patients with prolonged antibiotic use, those with indwelling devices such as central and peripheral vascular catheters that facilitate colonization and adherence, elderly individuals, surgical patients, and immunosuppressed individuals. Studies have shown that colonization can persist for months or even years. C. auris may lead to a variety of infections, including bloodstream infections, myocarditis, surgical site infections, burn wound infections, catheter site abscesses, otitis, meningitis, and bone and joint infections. Whenever possible, infected or colonized patients should be cared for in single-occupancy rooms, and education on hand hygiene and isolation precautions should be provided to patients, their families, and healthcare workers.
Keywords: Candida, Candidozyma auris, antifungal resistance, multidrug-resistant fungi, infection control
References
Pappas PG, Kauffman CA, Andes DR, et al. Clinical Practice Guideline for the Management of Candidiasis: 2016 Update by the Infectious Diseases Society of America. Clin Infect Dis. 2016;62:e1-50.
Colombo AL, de Almeida Júnior JN, Slavin MA, Chen SC, Sorrell TC. Candida and invasive mould diseases in non-neutropenic critically ill patients and patients with haematological cancer. Lancet Infect Dis. 2017;17:e344-56.
Satoh K, Makimura K, Hasumi Y, Nishiyama Y, Uchida K, Yamaguchi H. Candida auris sp. nov., a novel ascomycetous yeast isolated from the external ear canal of an inpatient in a Japanese hospital. Microbiol Immunol. 2009;53:41-4.
Lee WG, Shin JH, Uh Y, et al. First three reported cases of nosocomial fungemia caused by Candida auris. J Clin Microbiol. 2011;49:3139-42.
Calvo B, Melo AS, Perozo-Mena A, et al. First report of Candida auris in America: clinical and microbiological aspects of 18 episodes of candidemia. J Infect. 2016;73:369-74.
van Schalkwyk E, Mpembe RS, Thomas J, et al. Epidemiologic shift in Candidemia driven by Candida auris, South Africa, 2016-2017 1. Emerg Infect Dis. 2019;25:1698-1707.
Kurt AF, Kuskucu MA, Balkan II, et al. Candida auris fungemia and a local spread taken under control with infection control measures: first report from Turkey. Indian J Med Microbiol. 2021;39:228-30.
Bölükbaşı Y, Erköse Genç G, Orhun G, et al. Türkiye’de ilk COVID-19 pozitif Candida auris fungemi olgusu [First case of COVID-19 positive Candida auris fungemia in Turkey]. Mikrobiyol Bul. 2021;55:648-55.
Kömeç S, Karabıçak N, Ceylan AN, Gülmez A, Özalp O. Türkiye İstanbul’dan bildirilen üç Candida auris olgusu [Three Candida auris case reports from Istanbul, Turkey]. Mikrobiyol Bul. 2021;55:452-60. Turkish.
Kulaklı K, Arslan N, Gürsan O, Özkütük A. İzmir’den ilk Candida auris izolasyonu: amputasyon ile sonuçlanan polimikrobiyal diyabetik ayak enfeksiyonu. Turk Mikrobiyol Cemiy Derg. 2023;53:47-54.
Muñoz JF, Gade L, Chow NA, et al. Genomic insights into multidrug-resistance, mating and virulence in Candida auris and related emerging species. Nat Commun. 2018;9:5346
Chowdhary A, Sharma C, Duggal S, et al. New clonal strain of Candida auris, Delhi, India. Emerg Infect Dis. 2013;19:1670-3.
Hernando-Ortiz A, Mateo E, Perez-Rodriguez A, de Groot PWJ, Quindós G, Eraso E. Virulence of Candida auris from different clinical origins in Caenorhabditis elegans and Galleria mellonella host models. Virulence. 2021;12:1063-75.
Centers for Disease Control and Prevention. Tracking C. auris. Son Erişim Tarihi: 25.07.2025. Erişim Linki: https://www.cdc.gov/candida-auris/tracking-c-auris/index.html
Burki T. WHO publish fungal priority pathogens list. Lancet Microbe. 2023;4:e74.
Eix EF, Nett JE. Candida auris: epidemiology and antifungal strategy. Annu Rev Med. 2025;76:57-67.
T.C. Sağlık Bakanlığı Halk Sağlığı Genel Müdürlüğü. Sağlık hizmetlerinde Candida auris. 2025. Available from: https://hsgm.saglik.gov.tr/depo/birimler/bulasici-hastaliklar-ve-erken-uyari-db/Dokumanlar/Afisler-Brosurler/2025/Ek_Saglik_Hizmetlerinde_C._auris.pdf
Chowdhary A, Sharma C, Meis JF. Candida auris: a rapidly emerging cause of hospital-acquired multidrug-resistant fungal infections globally. PLoS Pathog. 2017;13:e1006290.
Casadevall A, Kontoyiannis DP, Robert V. On the emergence of Candida auris: climate change, azoles, swamps, and birds. mBio. 2019;10:e01397-19.
Akinbobola A, Kean R, Quilliam RS. Plastic pollution as a novel reservoir for the environmental survival of the drug resistant fungal pathogen Candida auris. Mar Pollut Bull. 2024;198:115841.
Harris A, Sansom SE, Hayden MK, et al. Risk factors for contamination of healthcare personnel gloves and gown with Candida auris (C. auris). OFID. 2025;12(Suppl 1):ofae631.1447.
Briano F, Magnasco L, Sepulcri C, et al. Candida auris Candidemia in critically Ill, colonized patients: cumulative incidence and risk factors. Infect Dis Ther. 2022;11:1149-60.
Schelenz S, Hagen F, Rhodes JL, et al. First hospital outbreak of the globally emerging Candida auris in a European hospital. Antimicrob Resist Infect Control. 2016;5:35.
Cortegiani A, Misseri G, Fasciana T, Giammanco A, Giarratano A, Chowdhary A. Epidemiology, clinical characteristics, resistance, and treatment of infections by Candida auris. J Intensive Care. 2018;6:69.
Sarma S, Upadhyay S. Current perspective on emergence, diagnosis and drug resistance in Candida auris. Infect Drug Resist. 2017;10:155-65.
Choi HI, An J, Hwang JJ, Moon SY, Son JS. Otomastoiditis caused by Candida auris: case report and literature review. Mycoses. 2017;60:488-92.
Chen J, Tian S, Han X, et al. Is the superbug fungus really so scary? A systematic review and meta-analysis of global epidemiology and mortality of Candida auris. BMC Infect Dis. 2020;20:827.
Zhang SX, Carroll KC, Lewis S, et al. Multicenter evaluation of a PCR-based digital microfluidics and electrochemical detection system for the rapid identification of 15 fungal pathogens directly from positive blood cultures. J Clin Microbiol. 2020;58:e02096-19.
Centers for Disease Control and Prevention. Identification of C. auris. Son Erişim Tarihi: 25.07.2025. Erişim Linki:https://www.cdc.gov/candida-auris/hcp/laboratories/identification-of-c-auris.html
Centers for Disease Control and Prevention. Guidance for detection of C. auris colonization. Son Erişim Tarihi: 25.07.2025. Erişim Linki: https://www.cdc.gov/candida-auris/hcp/laboratories/detection-colonization.html
Kim HY PhD, Nguyen TA MSc, et al. Candida auris-a systematic review to inform the world health organization fungal priority pathogens list. Med Mycol. 2024;62:myae042.
Centers for Disease Control and Prevention. Clinical treatment of C. auris infections. Available from: https://www.cdc.gov/candida-auris/hcp/clinical-care/index.html
Ahmad S, Khan Z, Al-Sweih N, Alfouzan W, Joseph L. Candida auris in various hospitals across Kuwait and their susceptibility and molecular basis of resistance to antifungal drugs. Mycoses. 2020;63:104-12.
Kordalewska M, Lee A, Park S, et al. Understanding echinocandin resistance in the emerging pathogen Candida auris. Antimicrob Agents Chemother. 2018;62:e00238-18.
Srivastava V, Ahmad A. Abrogation of pathogenic attributes in drug resistant Candida auris strains by farnesol. PLoS One. 2020;15:e0233102.
Dekkerová J, Černáková L, Kendra S, et al. Farnesol boosts the antifungal effect of fluconazole and modulates resistance in Candida auris through Regulation of the CDR1 and ERG11 genes. J Fungi (Basel). 2022;8:783.
Černáková L, Roudbary M, Brás S, Tafaj S, Rodrigues CF. Candida auris: a quick review on identification, current treatments, and challenges. Int J Mol Sci. 2021;22:4470.
Aldejohann AM, Wiese-Posselt M, Gastmeier P, Kurzai O. Expert recommendations for prevention and management of Candida auris transmission. Mycoses. 2022;65:590-8.
Centers for Disease Control and Prevention. Infection Control Guidance: Candida auris. Son Erişim Tarihi: 25.07.2025. Erişim Linki: https://www.cdc.gov/candida-auris/hcp/infection-control/index.html
